Arthur M D Braakenburg1, Aniki Rothova. 1. Department of Ophthalmology, University Medical Center Utrecht, The Netherlands. a.braakenburg@vumc.cl
Abstract
PURPOSE: To evaluate the ocular characteristics of active ocular toxoplasmosis (OT) during pregnancy in nine female patients and to compare these attacks with those in the nonpregnant periods. METHODS: Retrospective analysis of active OT during pregnancy and the nonpregnant periods. Outcome measurements consisted of the duration of attacks, the size of the retinal lesions, treatment strategies, and diverse ocular features and outcomes. RESULTS: The 9 patients had 10 attacks during pregnancy and 24 attacks while not pregnant. One woman had recurrences during several pregnancies, and in total, three female patients had attacks only when pregnant. In general, the severity of the attacks during the pregnant and nonpregnant periods did not differ. CONCLUSION: The attacks during pregnancy were not distinctively different in severity, duration, or outcome from the OT attacks outside pregnancy.
PURPOSE: To evaluate the ocular characteristics of active ocular toxoplasmosis (OT) during pregnancy in nine female patients and to compare these attacks with those in the nonpregnant periods. METHODS: Retrospective analysis of active OT during pregnancy and the nonpregnant periods. Outcome measurements consisted of the duration of attacks, the size of the retinal lesions, treatment strategies, and diverse ocular features and outcomes. RESULTS: The 9 patients had 10 attacks during pregnancy and 24 attacks while not pregnant. One woman had recurrences during several pregnancies, and in total, three female patients had attacks only when pregnant. In general, the severity of the attacks during the pregnant and nonpregnant periods did not differ. CONCLUSION: The attacks during pregnancy were not distinctively different in severity, duration, or outcome from the OT attacks outside pregnancy.
Authors: Arthur M D Braakenburg; Catherine M Crespi; Gary N Holland; Sheng Wu; Fei Yu; Aniki Rothova Journal: Am J Ophthalmol Date: 2014-01-09 Impact factor: 5.258